![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1354306
¼¼°èÀÇ Ã´ÃßÈı¼º¹¿ø¼ú ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(-2032³â)Kyphoplasty Market Size By Product, By Application, By Indication, By End-use - Global Forecast to 2032 |
¼¼°è ôÃßÈı¼º¹¿ø¼ú ½ÃÀå ±Ô¸ð´Â 2023-2032³â°£ 5.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
±âÁ¸ÀÇ °³º¹ ¼ö¼ú¿¡ ºñÇØ ȸº¹ ½Ã°£ÀÌ Âª°í ÇÕº´Áõ À§ÇèÀÌ ³·¾Æ ȯÀÚ ¹× ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü »çÀÌ¿¡¼ ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÔ¿ø ±â°£ ´ÜÃà, ¼ö¼ú ÈÄ °ü¸® ±â°£ ´ÜÃà µî ºñ¿ë È¿À²ÀûÀÎ ¿É¼ÇÀ» Á¦°øÇÏ´Â °ñ Ä«ÀÌÆ÷ÇÃ¶ó½ºÆ¼ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ȯÀÚÀÇ °á°ú¿Í °æÇèÀ» °³¼±Çϱâ À§ÇØ °¡Ä¡ ±â¹Ý ÀÇ·á·Î ÀüȯÇÏ´Â Ãß¼¼µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Ä«ÀÌÆ÷ÇÃ¶ó½ºÆ½ »ê¾÷ Àüü´Â Á¦Ç°, ¿ëµµ, ÀûÀÀÁõ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.
Á¦Ç°º°·Î´Â dz¼± Ä«Å×ÅÍ ½ÃÀå °¡Ä¡´Â 2032³â±îÁö È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. dz¼± Ä«Å×ÅÍ´Â ÀÇ·áÁøÀÌ Ã´ÃßÀÇ À§Ä¡¿Í ³ôÀ̸¦ º¹¿øÇϰí ÅëÁõÀ» ÁÙÀÌ°í ¿µÇâÀ»¹ÞÀº ôÃß¿¡ ±¸Á¶Àû Áö¿øÀ» Á¦°øÇÒ ¼ö ÀÖµµ·Ï Ä«ÀÌ·ÎÇÁ·¢Æ½ÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î ¹ßÀüÇØ ¿Ô½À´Ï´Ù.
¿ëµµ Ãø¸é¿¡¼´Â ôÃß Á¤·Ä º¹¿ø ºÎ¹®¿¡¼ Ä«ÀÌÆ÷ÇÃ¶ó½ºÆ¼ÀÇ »ê¾÷ ±Ô¸ð°¡ 2032³â±îÁö È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ôÃß ¾Ð¹Ú °ñÀý°ú °ü·ÃµÈ ½ÉÇÑ ÅëÁõÀ» ¿ÏÈÇÏ´Â Ä«ÀÌÆ÷ÇÃ¶ó½ºÆ¼°¡ ȯÀڵ鿡°Ô ºü¸¥ ÅëÁõ ¿Ïȸ¦ °¡Á®´ÙÁֱ⠶§¹®¿¡ ¼±ÅÃÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÎ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÅëÁõ °ü¸® ¹× º¸Á¶±â Âø¿ë°ú °°Àº º¸Á¸Àû Ä¡·áÀÇ ÇѰ赵 ÀÌ ºÐ¾ß È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áö¿ªº°·Î º¸¸é, À¯·´ÀÇ Ä«ÀÌÆ÷ÇÃ¶ó½ºÆ¼ ½ÃÀå ±Ô¸ð´Â ȸº¹ ½Ã°£ÀÌ Âª°í ¼ö¼ú ÈÄ ÅëÁõÀÌ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ 2032³â±îÁö °ßÁ¶ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, º¸Çè ȯ±Þ Á¤Ã¥ ¹× ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±À¸·Î ȯÀڵ鿡°Ô º¸´Ù Ä£¼÷ÇÏ°Ô ´Ù°¡°¥ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. NHS England¿¡ µû¸£¸é ¿µ±¹¿¡¼´Â ¸Å³â ¾à 300¸¸ ¸íÀÌ °ñ´Ù°øÁõÀ» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Àα¸ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ¿Í °ñ´Ù°øÁõ ºÎ´ã Áõ°¡´Â Áö¿ª »ê¾÷ÀÇ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
Global Kyphoplasty Market size is poised to record 5.5% CAGR from 2023-2032.
The demand for minimally invasive surgical techniques among patients and healthcare providers is significantly soaring due to their reduced recovery times and mitigated risks of complications over traditional open surgeries. To that end, kyphoplasty has grown largely popular as it renders cost-effective alternatives with decreased hospital stays and higher need for prolonged post-operative care. The rising shift towards value-based healthcare for improved patient outcomes and experiences will also contribute to the market growth.
The overall kyphoplasty industry is segmented based on product, application, indication, end-use, and region.
In terms of product, the market value from the balloon catheters segment will witness expansion through 2032 driven by their optimum packaging in sterile conditions for preventing infection during the treatment procedures. Balloon catheters have evolved as critical components of kyphoplasty as they assist healthcare providers to restore vertebral alignment and height, limit pain, and offer structural support to the affected vertebra.
With respect to application, the kyphoplasty industry size from the vertebral alignment restoration segment is expected to expand up to 2032. The growth can be attributed to the increasing preference for kyphoplasty in alleviating severe pain related to vertebral compression fractures as it renders rapid relief to patients. The limitations of conservative treatments, including pain management and bracing will also add to the segment expansion.
Regionally, Europe kyphoplasty market size is expected to observe robust growth through 2032 due to the growing preference for minimally invasive surgical techniques due to their shorter recovery times and limited post-operative pain. The rising improvements in reimbursement policies as well as healthcare infrastructure has also made kyphoplasty more accessible to patients. The rapidly aging population base and the growing burden of osteoporosis will contribute to the regional industry growth. As per NHS England, around 3 million individuals are estimated to suffer from osteoporosis in the U.K. each year.